Further supporting the pro-oncogenic function of MEX3A, in vitro data showed that its overexpression promotes proliferation in HCT116 human colon cancer cell line (Figure S5B-D), and shifted relative cell cycle phase distribution toward S phase (Figure S5E). Here, MEX3A is linked to colonic neoplasm.